The global Real-Time PCR, Digital PCR, And End-Point PCR Market size are expected to reach USD 14.63 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to decline at a compound annual growth rate (CAGR) of 8.2% from 2022 to 2030. However, the real global real-time PCR, digital PCR, and end-point PCR market without the impact of the COVID-19 pandemic is expected to expand at a compound annual growth rate (CAGR) of 8.0% from 2022 to 2030. Digital PCR is a novel technique for absolute quantification and analysis of minority sequences in the presence of similar majority sequences. dPCR allows for precise and sensitive nucleic acid measurement. In addition, real-time PCR provides precise and early diagnosis of diseases and rapid and targeted patient care hence anticipated to increase the demand in the coming years.
The rise in the occurrence of diseases such as lung
cancer, blood cancer, and brain tumors is fueling the application expansion of
the global market. According to Globocan 2020, lung cancer is the second most
common cancer in Europe, with an estimated 477,534 newly diagnosed cases.
Furthermore, the benefits of digital polymerase chain reaction over traditional
technologies such as real-time and quantitative polymerase chain reaction are
likely to drive adoption throughout the forecast period. Moreover, rising
healthcare expenditures in emerging nations and the increased need for accurate
molecular disease detection are propelling the market growth.
Furthermore, the COVID-19 pandemic has increased the
demand for digital PCR instruments and reagents. COVID-19 infections are
detected using modern digital PCR instruments as a molecular diagnosis
technique. According to the WHO, around 273 million cases have been diagnosed
and roughly 5.3 million deaths have been documented worldwide due to COVID-19
as of December 2021. Moreover, in the pharmaceutical industry, digital PCR
machines are also employed in R&D.
Furthermore, advancements in technology and an
increase in the number of product launches in the global market are expected to
support the market growth. For instance, in June 2021, Bio-Rad Laboratories,
Inc. announced the release of the PREvalence ddPCR SARS-CoV-2 waste-water
quantifying kit for COVID-19 wastewater screening.
Additionally, the increase in R&D projects for
advancements in technology and an increase in collaborations between firms for
the development of digital polymerase chain reactions are expected to increase
the usage of PCR testing. For instance, Qiagen partnered with Atila BioSystems
& Actome GmbH in January 2022 to deliver non-invasive prenatal testing
(NIPT) technologies to QIAGEN's dPCR for a growing number of applications for
QIAcuity. As a result, the usage of real-time and digital PCR technologies is
projected to increase during the forecast period.
Related Press Release@ Real-time PCR, Digital PCR, And End-point PCR Market Report
Real-time PCR, Digital PCR, And
End-point PCR Market Report Highlights
- By technology, the quantitative segment held the largest revenue
share in 2021. This is attributed to the high adoption of technology
supported by the introduction of products based on real-time polymerase
chain reaction for screening and diagnosis of COVID-19
- The consumables and reagents product segment dominated the market
in 2021 due to the increased demand for earlier detection and the number
of significant companies manufacturing digital PCR consumables and
reagents
- North America dominated the global market in 2021 due to the
presence of high R&D investment, the availability of a technologically
advanced healthcare research framework, the strong presence of
prominent polymerase chain reaction manufacturers, and an expanding
requirement for rapid diagnostic tests in the region
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment